v3.25.2
Consolidated Statements of Changes in Equity
$ in Millions
USD ($)
shares
Opening Balance After Adjustment Cumulative Effect at Date of Initial Application
Amendments To IAS 37
USD ($)
Cumulative Effect Adjustment To Equity
Amendments To IAS 37
USD ($)
 [1]
Issued capital [member]
USD ($)
shares
Issued capital [member]
Opening Balance After Adjustment Cumulative Effect at Date of Initial Application
Amendments To IAS 37
USD ($)
shares
Share Premium
USD ($)
Share Premium
Opening Balance After Adjustment Cumulative Effect at Date of Initial Application
Amendments To IAS 37
USD ($)
Retained Earnings
USD ($)
Retained Earnings
Opening Balance After Adjustment Cumulative Effect at Date of Initial Application
Amendments To IAS 37
USD ($)
Retained Earnings
Cumulative Effect Adjustment To Equity
Amendments To IAS 37
USD ($)
 [1]
Other Reserves
USD ($)
Other Reserves
Opening Balance After Adjustment Cumulative Effect at Date of Initial Application
Amendments To IAS 37
USD ($)
Capital Redemption Reserve
USD ($)
Capital Redemption Reserve
Opening Balance After Adjustment Cumulative Effect at Date of Initial Application
Amendments To IAS 37
USD ($)
Cash Flow Hedge Reserve
USD ($)
Cash Flow Hedge Reserve
Opening Balance After Adjustment Cumulative Effect at Date of Initial Application
Amendments To IAS 37
USD ($)
Other Components of Equity
USD ($)
Other Components of Equity
Opening Balance After Adjustment Cumulative Effect at Date of Initial Application
Amendments To IAS 37
USD ($)
Total equity attributable to equity holders of the company
USD ($)
Total equity attributable to equity holders of the company
Opening Balance After Adjustment Cumulative Effect at Date of Initial Application
Amendments To IAS 37
USD ($)
Total equity attributable to equity holders of the company
Cumulative Effect Adjustment To Equity
Amendments To IAS 37
USD ($)
 [1]
Non-controlling interest
USD ($)
Non-controlling interest
Opening Balance After Adjustment Cumulative Effect at Date of Initial Application
Amendments To IAS 37
USD ($)
Balance at Mar. 31, 2022 $ 9,994 $ 9,992 $ (2) $ 328 $ 328 $ 337 $ 337 $ 11,672 $ 11,670 $ (2) $ 1,170 $ 1,170 $ 21 $ 21 $ 1 $ 1 $ (3,588) $ (3,588) $ 9,941 $ 9,939 $ (2) $ 53 $ 53
Balance, Shares at Mar. 31, 2022 | shares [2]       4,193,012,929 4,193,012,929                                    
Changes in equity for the year                                              
Net Profit 2,983             2,981                     2,981     2  
Remeasurement of the net defined benefit liability/asset, net* [3] 4                               4   4        
Equity instruments through other comprehensive income, net* (Refer to Notes 2.2 and 2.18) [3] (3)                               (3)   (3)        
Fair value changes on investments, net* (Refer to Notes 2.2 and 2.18) [3] (30)                               (30)   (30)        
Fair value changes on derivatives designated as cash flow hedge, net* (Refer to Notes 2.3 and 2.18) [3] (1)                           (1)       (1)        
Exchange differences on translation of foreign operations (697)                               (697)   (697)        
Total comprehensive income 2,256             2,981             (1)   (726)   2,254     2  
Shares issued on exercise of employee stock options (Refer to note 2.17) 4         4                         4        
Shares issued on exercise of employee stock options (Refer to note 2.17), Shares | shares [2]       3,801,344                                      
Buyback of equity shares (Refer to Note 2.15) [4] (1,394)     $ (3)   (41)   (1,350)                     (1,394)        
Buyback of equity shares (Refer to note 2.15), Shares | shares [2],[4]       (60,426,348)                                      
Transaction cost relating to buyback* (Refer to Note 2.15) [3] (3)         (3)                         (3)        
Amount transferred to capital redemption reserve upon buyback (Refer to Note 2.15)               (3)         3                    
Transfer to other reserves               (380)     380                        
Transfer from other reserves on utilization               180     (180)                        
Employee stock compensation expense (Refer to note 2.17) 63         63                         63        
Income tax benefit arising on exercise of stock options 6         6                         6        
Dividends paid to non-controlling interest of subsidiary (3)                                         (3)  
Dividends [1] (1,697)             (1,697)                     (1,697)        
Balance at Mar. 31, 2023 9,224     $ 325   366   11,401     1,370   24       (4,314)   9,172     52  
Balance, Shares at Mar. 31, 2023 | shares [2]       4,136,387,925                                      
Changes in equity for the year                                              
Net Profit 3,169             3,167                     3,167     2  
Remeasurement of the net defined benefit liability/asset, net* [3] 15                               15   15        
Equity instruments through other comprehensive income, net* (Refer to Notes 2.2 and 2.18) [3] 2                               2   2        
Fair value changes on investments, net* (Refer to Notes 2.2 and 2.18) [3] 17                               17   17        
Fair value changes on derivatives designated as cash flow hedge, net* (Refer to Notes 2.3 and 2.18) 1                           1 [3]   1 [3]   1 [3]        
Exchange differences on translation of foreign operations (117)                               (116)   (116)     (1)  
Total comprehensive income 3,087             3,167             1   (82)   3,086     1  
Shares issued on exercise of employee stock options (Refer to note 2.17) 1         1                         1        
Shares issued on exercise of employee stock options (Refer to note 2.17), Shares | shares [2]       3,562,710                                      
Transferred on account of options not exercised           (19)   19                              
Transfer to other reserves               (357)     357                        
Transfer from other reserves on utilization               104     (104)                        
Employee stock compensation expense (Refer to note 2.17) 77         77                         77        
Buyback of shares pertaining to non controlling interest of subsidiary (2)                                         (2)  
Dividends paid to non-controlling interest of subsidiary (5)                                         (5)  
Dividends [5] (1,777)             (1,777)                     (1,777)        
Balance at Mar. 31, 2024 $ 10,605     $ 325   425   12,557     1,623   24   1   (4,396)   10,559     46  
Balance, Shares at Mar. 31, 2024 | shares 4,139,950,635     4,139,950,635 [2]                                      
Changes in equity for the year                                              
Net Profit $ 3,162             3,158                     3,158     4  
Remeasurement of the net defined benefit liability/asset, net* [3] (11)                               (11)   (11)        
Equity instruments through other comprehensive income, net* (Refer to Notes 2.2 and 2.18) [3] 2                               2   2        
Fair value changes on investments, net* (Refer to Notes 2.2 and 2.18) [3] 24                               24   24        
Fair value changes on derivatives designated as cash flow hedge, net* (Refer to Notes 2.3 and 2.18) [3] (3)                           (3)       (3)        
Exchange differences on translation of foreign operations (198)                               (198)   (198)        
Total comprehensive income 2,976             3,158             (3)   (183)   2,972     4  
Shares issued on exercise of employee stock options (Refer to note 2.17) 1         1                         1        
Shares issued on exercise of employee stock options (Refer to note 2.17), Shares | shares [2]       3,656,893                                      
Transferred on account of options not exercised           (23)   23                              
Transfer to other reserves               (9)     9                        
Transfer from other reserves on utilization               104     (104)                        
Employee stock compensation expense (Refer to note 2.17) 93         93                         93        
Income tax benefit arising on exercise of stock options 4         4                         4        
Transferred from other reserves to retained earnings               357     (357)                        
Dividends [5] (2,424)             (2,424)                     (2,424)        
Balance at Mar. 31, 2025 $ 11,255     $ 325   $ 500   $ 13,766     $ 1,171   $ 24   $ (2)   $ (4,579)   $ 11,205     $ 50  
Balance, Shares at Mar. 31, 2025 | shares 4,143,607,528     4,143,607,528 [2]                                      
[1] Impact on account of adoption of amendment to IAS 37 Provisions, Contingent Liabilities and Contingents Assets
[2] excludes treasury shares of 9,655,927 as of March 31, 2025, 10,916,829 as of March 31, 2024, 12,172,119 as of March 31, 2023, and 13,725,712 as of April 1, 2022, held by consolidated trust.
[3] net of taxes
[4] including tax on buyback $264 million for the years ended March 31, 2023.
[5] net of treasury shares